HomeCompareRHILF vs JNJ

RHILF vs JNJ: Dividend Comparison 2026

RHILF yields 178.57% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RHILF wins by $62.89M in total portfolio value
10 years
RHILF
RHILF
● Live price
178.57%
Share price
$1.12
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62.91M
Annual income
$29,936,192.20
Full RHILF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RHILF vs JNJ

📍 RHILF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRHILFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RHILF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RHILF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHILF
Annual income on $10K today (after 15% tax)
$15,178.57/yr
After 10yr DRIP, annual income (after tax)
$25,445,763.37/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RHILF beats the other by $25,445,059.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHILF + JNJ for your $10,000?

RHILF: 50%JNJ: 50%
100% JNJ50/50100% RHILF
Portfolio after 10yr
$31.47M
Annual income
$14,968,509.99/yr
Blended yield
47.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RHILF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHILF buys
0
JNJ buys
0
No recent congressional trades found for RHILF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRHILFJNJ
Forward yield178.57%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$62.91M$20.0K
Annual income after 10y$29,936,192.20$827.78
Total dividends collected$58.90M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RHILF vs JNJ ($10,000, DRIP)

YearRHILF PortfolioRHILF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$28,557$17,857.14$10,676$355.77+$17.9KRHILF
2$78,215$47,658.78$11,407$389.39+$66.8KRHILF
3$205,683$121,992.76$12,198$426.53+$193.5KRHILF
4$519,899$299,818.53$13,056$467.62+$506.8KRHILF
5$1,264,557$708,265.17$13,987$513.12+$1.25MRHILF
6$2,963,097$1,610,021.03$14,998$563.56+$2.95MRHILF
7$6,696,294$3,525,779.94$16,098$619.52+$6.68MRHILF
8$14,611,669$7,446,634.50$17,295$681.69+$14.59MRHILF
9$30,820,422$15,185,936.42$18,599$750.82+$30.80MRHILF
10$62,914,044$29,936,192.20$20,022$827.78+$62.89MRHILF

RHILF vs JNJ: Complete Analysis 2026

RHILFStock

Round Hill Music Royalty Fund Limited invests in music intellectual property. It owns and operates a portfolio of 49 catalogues of music copyright properties. The company was incorporated in 2020 and is based in Saint Peter Port, the Channel Islands.

Full RHILF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RHILF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHILF vs SCHDRHILF vs JEPIRHILF vs ORHILF vs KORHILF vs MAINRHILF vs ABBVRHILF vs MRKRHILF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.